YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis
-
- Christian Østergaard
- Division of Microbiology, Department of Research and Development, Statens Serum Institut, Copenhagen
-
- Julia S. Johansen
- Division of Microbiology, Department of Research and Development, Statens Serum Institut, Copenhagen
-
- Thomas Benfield
- Division of Microbiology, Department of Research and Development, Statens Serum Institut, Copenhagen
-
- Paul A. Price
- Division of Microbiology, Department of Research and Development, Statens Serum Institut, Copenhagen
-
- Jens D. Lundgren
- Division of Microbiology, Department of Research and Development, Statens Serum Institut, Copenhagen
抄録
<jats:title>ABSTRACT</jats:title><jats:p>YKL-40, a member of the family 18 glycosyl hydrolases, is secreted by activated neutrophils and macrophages. It is a growth factor for connective tissue cells and a potent migration factor for endothelial cells and may function in inflammation and tissue remodeling. YKL-40 was determined in 134 cerebrospinal fluid (CSF) samples taken on admission from patients suspected of having meningitis (48 with purulent meningitis, 49 with lymphocytic meningitis, 5 with encephalitis, and 32 without evidence of meningitis). YKL-40 levels in CSF were significantly higher in patients with purulent meningitis (median, 663 μg/liter [range, 20 to 8,960]) and encephalitis (5,430 μg/liter [620 to 11,600]) than in patients with lymphocytic meningitis (137 μg/liter [41 to 1,865]) or patients without meningitis (167 μg/liter [24 to 630]) (Kruskal-Wallis and Dunn multiple comparison tests,<jats:italic>P</jats:italic>< 0.001). CSF YKL-40 levels were also determined for 26 patients with purulent meningitis having a repuncture, and patients who died (<jats:italic>n</jats:italic>= 5) had significantly higher YKL-40 levels than patients who survived (<jats:italic>n</jats:italic>= 21) (2,100 μg/liter [1,160 to 7,050] versus 885 μg/liter [192 to 15,400], respectively; Mann-Whitney test,<jats:italic>P</jats:italic>= 0.018). YKL-40 was most likely locally produced, since patients with infections of the central nervous system had CSF YKL-40 levels that were at least 10-fold higher than the corresponding levels in serum (2,033 μg/liter [470 to 11,600] versus 80 μg/liter [19 to 195]). The CSF neopterin level was the biochemical parameter in CSF and blood that correlated best with CSF YKL-40 levels, indicating that YKL-40 may be produced by activated macrophages within the central nervous system. In conclusion, high levels of YKL-40 in CSF are found in patients with purulent meningitis.</jats:p>
収録刊行物
-
- Clinical and Vaccine Immunology
-
Clinical and Vaccine Immunology 9 (3), 598-604, 2002-05
American Society for Microbiology
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360017284857570816
-
- NII論文ID
- 30020655032
-
- ISSN
- 1556679X
- 15566811
-
- データソース種別
-
- Crossref
- CiNii Articles